Biotechnology News

MALVERN, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...

Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026

TME Pharma Publishes Its Semi Annual Results and Half-Year Report Berlin, Germany, October 30, 2026, 18:00 CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotech-company with clinical assets...

TME Pharma publie ses résultats semestriels et son rapport semestriel Berlin, Allemagne, le 30 octobre 2026, 18 h 00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de...

First FDA-approved biologic specifically designed to cross blood-brain barrier wins award dedicated to exceptional scientific leadership and transformational impact on patient careFirst new...

Kraig Labs (OTCQB: KBLB) shipped its spider silk super fibers to a company with experience developing materials alongside major aerospace manufacturers.

Strategic Combination Brings Highly Innovative Late-Stage D-Fi Franchise Targeting Rare Diseases, with Orphan Drug-Designated Lead Indication in Dystrophic Epidermolysis Bullosa (DEB) Combines Two...

Presentation to explore the potential of RNA-splicing payloads to drive broad anti-tumor effects through direct cell killing along with immune activation  Satyajit Mitra, Executive Director, Head of...

KUALA LUMPUR, Malaysia, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (“Alps” or “the Company”) (Nasdaq: ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced...

Biocartis announced that an abstract on its Idylla™ Breast21 Assay has been accepted for poster presentation at the San Antonio Breast Cancer Symposium.